Betta Pharmaceuticals Co., Ltd.
SZSE:300558.SZ
56.19 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 471.683 | 751.997 | 731.285 | 791.99 | 1,345.945 | 521.298 | 304.969 | 213.273 | 153.95 | 260.106 | 197.766 | 186.424 | 31.879 | 19.674 |
| Short Term Investments
| 126.439 | 0.54 | -32.682 | 201.006 | -36.985 | -576.454 | -506.771 | -2.094 | 975 | 220 | 0 | 0.327 | 0.468 | 0.437 |
| Cash and Short Term Investments
| 598.122 | 752.536 | 731.285 | 992.995 | 1,345.945 | 521.298 | 304.969 | 213.273 | 153.95 | 260.106 | 197.766 | 186.751 | 32.347 | 20.111 |
| Net Receivables
| 100.299 | 286.41 | 450.625 | 173.381 | 0 | 56.029 | 63.814 | 91.973 | 94.645 | 0 | 15.98 | 0 | 4.697 | 0 |
| Inventory
| 290.085 | 327.502 | 372.173 | 293.322 | 188.594 | 134.569 | 144.994 | 99.756 | 74.977 | 47.155 | 33.447 | 27.219 | 18.539 | 11.471 |
| Other Current Assets
| 235.825 | 159.432 | 178.752 | 194.238 | 70.714 | 80.346 | 60.985 | 101.525 | 980.121 | 220.58 | 14.316 | 1.129 | 8.202 | 8.64 |
| Total Current Assets
| 1,224.331 | 1,525.881 | 1,732.835 | 1,653.936 | 1,847.866 | 792.241 | 574.761 | 506.527 | 1,303.693 | 560.212 | 261.509 | 222.975 | 63.785 | 40.223 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 3,008.839 | 2,590.595 | 2,056.336 | 1,330.992 | 775.719 | 788.979 | 815.094 | 863.15 | 558.18 | 274.673 | 155.146 | 96.724 | 81.249 | 79.904 |
| Goodwill
| 413.584 | 413.584 | 413.584 | 413.584 | 413.584 | 427.455 | 413.584 | 413.584 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 3,159.59 | 3,162.129 | 2,662.857 | 2,434.469 | 1,774.81 | 1,398.565 | 1,056.053 | 823.483 | 155.399 | 174.32 | 178.179 | 86.569 | 85.333 | 90.82 |
| Goodwill and Intangible Assets
| 3,573.174 | 3,575.713 | 3,076.441 | 2,848.053 | 2,188.394 | 1,826.019 | 1,469.637 | 1,237.067 | 155.399 | 174.32 | 178.179 | 86.569 | 85.333 | 90.82 |
| Long Term Investments
| 1,310.17 | 1,415.591 | 951.948 | 144.783 | 311.534 | 695.177 | 592.617 | 154.356 | 143.17 | 130.307 | 60.774 | 0 | 0 | 0 |
| Tax Assets
| 56.732 | 39.129 | 85.965 | 55.062 | 55.223 | 29.493 | 7.809 | 7.159 | 6.718 | 5.712 | 4.001 | 3.633 | 4.856 | 4.166 |
| Other Non-Current Assets
| 168.433 | 0 | 6.622 | 238.607 | 50.802 | 1.425 | 0.168 | 4.754 | 0.143 | 1.821 | 3.32 | 0.906 | 25.781 | 0 |
| Total Non-Current Assets
| 8,117.347 | 7,621.028 | 6,177.312 | 4,617.496 | 3,381.672 | 3,341.093 | 2,885.324 | 2,266.486 | 863.61 | 586.833 | 401.42 | 187.832 | 197.219 | 174.89 |
| Total Assets
| 9,341.678 | 9,146.908 | 7,910.147 | 6,271.432 | 5,229.538 | 4,133.334 | 3,460.086 | 2,773.014 | 2,167.303 | 1,147.045 | 662.928 | 410.807 | 261.003 | 215.112 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 746.108 | 800.118 | 591.011 | 431.187 | 113.624 | 112.55 | 188.328 | 121.788 | 47.752 | 23.037 | 10.436 | 5.385 | 9.893 | 2.873 |
| Short Term Debt
| 100.081 | 606.124 | 640.196 | 0 | 0 | 363.235 | 360 | 200 | 0 | 0 | 0 | 0 | 2 | 101.75 |
| Tax Payables
| 27.243 | 0.066 | 21.105 | 66.474 | 100.324 | 25.107 | 4.679 | 15.151 | 22.791 | 23.683 | 11.253 | 12.536 | 16.845 | 4.934 |
| Deferred Revenue
| 0 | 0 | 4.459 | 452.187 | 2.748 | 176.256 | 4.679 | 195.328 | 0 | 82.482 | 69.496 | 0 | 42.26 | 14.663 |
| Other Current Liabilities
| 974.527 | 396.849 | 386.851 | -60.99 | 221.404 | 152.988 | 193.426 | -15.076 | 134.881 | 91.649 | 65.251 | 38.755 | 42.279 | 9.741 |
| Total Current Liabilities
| 1,847.96 | 1,803.157 | 2,104.781 | 888.859 | 438.1 | 705.197 | 751.112 | 517.192 | 205.424 | 138.369 | 86.94 | 56.676 | 71.017 | 119.299 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 1,554.043 | 1,824.183 | 663.328 | 6.337 | 524.589 | 280 | 280 | 100 | 0 | 85.4 | 10.615 | 15 | 0 | 14 |
| Deferred Revenue Non-Current
| 150.99 | 144.703 | 112.765 | 111.998 | 58.013 | 57.775 | 35.812 | 34.649 | 31.943 | 28.536 | 21.956 | 20.032 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 53.488 | 23.392 | 71.572 | 68.392 | 64.64 | 63.05 | 54.186 | 54.643 | 0.898 | 0.786 | 0.385 | -15.379 | 0 | 0 |
| Other Non-Current Liabilities
| 69.088 | 0 | 0 | 622.054 | 518.762 | 558.096 | 198.944 | 0 | 0 | 0 | 0 | 0 | 17.425 | 29.534 |
| Total Non-Current Liabilities
| 1,827.608 | 1,992.278 | 847.665 | 696.783 | 647.242 | 958.921 | 507.262 | 189.291 | 32.841 | 114.722 | 32.957 | 35.032 | 17.425 | 43.534 |
| Total Liabilities
| 3,675.567 | 3,795.435 | 2,952.445 | 1,585.642 | 1,085.343 | 1,664.119 | 1,258.373 | 706.483 | 238.265 | 253.091 | 119.897 | 91.708 | 88.443 | 162.832 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0 | 0 | 0 |
| Common Stock
| 418.486 | 418.486 | 417.467 | 415.389 | 413.163 | 401 | 401 | 401 | 401 | 360 | 360 | 150 | 56.641 | 52.539 |
| Retained Earnings
| 2,624.648 | 2,293.221 | 1,971.158 | 1,929.585 | 1,673.375 | 1,143.295 | 1,004.231 | 921.98 | 768.659 | 438.56 | 129.075 | 67.329 | 65.136 | -32.632 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 593.917 | 600.429 | 467.193 | 403.393 | 331.774 | 240.499 | 137.488 | 136.31 | 89.756 | -0.002 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 2,530.673 | 1,945.453 | 2,460.436 | 1,748.721 | 1,650.541 | 916.244 | 824.969 | 744.156 | 754.672 | 0 | 46.207 | 91.941 | 49.758 | 32.373 |
| Total Shareholders Equity
| 5,573.806 | 5,251.077 | 4,849.061 | 4,560.888 | 4,140.781 | 2,460.54 | 2,187.733 | 2,051.962 | 1,924.331 | 888.316 | 535.282 | 309.27 | 171.535 | 52.28 |
| Total Equity
| 5,666.11 | 5,351.474 | 4,957.702 | 4,685.79 | 4,144.195 | 2,469.215 | 2,201.712 | 2,066.531 | 1,929.037 | 893.954 | 543.032 | 319.1 | 172.561 | 52.28 |
| Total Liabilities & Shareholders Equity
| 9,341.678 | 9,146.908 | 7,910.147 | 6,271.432 | 5,229.538 | 4,133.334 | 3,460.086 | 2,773.014 | 2,167.303 | 1,147.045 | 662.928 | 410.807 | 261.003 | 215.112 |